APA (7th ed.) Citation

Lai, P., Chen, X., Qin, L., Jiang, Z., Luo, C., Huang, X., . . . Weng, J. (2020). The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection. Leukemia, 34(10), 2790-2793. https://doi.org/10.1038/s41375-020-0952-4

Chicago Style (17th ed.) Citation

Lai, Peilong, et al. "The Efficacy and Safety of CAR-T Cell Therapy in Patients with Refractory ALL and Concomitant HBV Infection." Leukemia 34, no. 10 (2020): 2790-2793. https://doi.org/10.1038/s41375-020-0952-4.

MLA (9th ed.) Citation

Lai, Peilong, et al. "The Efficacy and Safety of CAR-T Cell Therapy in Patients with Refractory ALL and Concomitant HBV Infection." Leukemia, vol. 34, no. 10, 2020, pp. 2790-2793, https://doi.org/10.1038/s41375-020-0952-4.